Acarbose Cardiovascular Evaluation Trial (ACE)

A Long-term, Multicentre, Double-blind, Randomised Parallel-group Trial to Determine Whether Reducing Post-prandial Glycaemia Can Reduce Cardiovascular-related Morbidity and Mortality in Patients With Established Coronary Heart Disease or Acute Coronary Syndrome Who Have Impaired Glucose Tolerance

The purpose of this study is to determine whether acarbose therapy can reduce cardiovascular-related morbidity and mortality in patients with impaired glucose tolerance (IGT) who have established coronary heart disease (CHD) or acute coronary syndrome (ACS). A secondary objective of the study is to determine if acarbose therapy can prevent or delay transition to type 2 diabetes mellitus (T2DM) in this patient population.

Study Overview

• Status: Completed
• Conditions: Coronary Heart Disease; Acute Coronary Syndrome; Impaired Glucose Tolerance; Type 2 Diabetes Mellitus (T2DM)
• Intervention / Treatment: Drug: Acarbose; Drug: Matching Placebo

Detailed Description

A long-term, multicentre, double-blind, randomised parallel-group trial to determine whether reducing post-prandial glycaemia can reduce cardiovascular-related morbidity and mortality in patients with established coronary heart disease or acute coronary syndrome who have impaired glucose tolerance.

• Study Type: Interventional
• Enrollment (Actual): 6526
• Phase: Phase 4

Contacts and Locations

Study Locations

• China
  • Anhui
    • Hefei, Anhui, China, 230032
      • The First affiliated Hospital of Anhui Medical University
  • Beijing
    • Beijing, Beijing, China, 100034
      • Peking University First Hospital
    • Beijing, Beijing, China, 100730
      • Peking Union Medical College Hospital
    • Beijing, Beijing, China, 100053
      • Xuanwu Hospital Capital Medical University
    • Beijing, Beijing, China, 100044
      • Peking University People's Hospital
    • Beijing, Beijing, China, 100853
      • PLA General Hospital
    • Beijing, Beijing, China, 100029
      • China-Japan Friendship Hospital
    • Beijing, Beijing, China, 100028
      • China Meitan General Hospital
    • Beijing, Beijing, China, 100038
      • Beijing Shijitan Hospital
    • Beijing, Beijing, China, 100038
      • Fu Xing Hospital
    • Beijing, Beijing, China, 100035
      • Beijing Ji Shui Tan Hospital
    • Beijing, Beijing, China, 100022
      • Beijing Chuiyangliu Hospital
    • Beijing, Beijing, China, 100029
      • Beijing Anzhen Hospital of the Capital University of Medical Sciences
    • Beijing, Beijing, China, 100043
      • Beijing Shijingshan Hospital
    • Beijing, Beijing, China, 100049
      • Aerospace Central Hospital
    • Beijing, Beijing, China, 100050
      • Affiliated to The Capital University of Medical Sciences Beijing Friendship Hospital
    • Beijing, Beijing, China, 100053
      • Wangjing Hospital of CACMS
    • Beijing, Beijing, China, 100054
      • Beijing Healthy Palace Hospital
    • Beijing, Beijing, China, 100074
      • Aerospace 731 Hospital
    • Beijing, Beijing, China, 100088
      • General Hospital of Second Artillery PLA
    • Beijing, Beijing, China, 101200
      • Anzhen Hospital of The Capital University of Medical Sciences 2nd.
    • Beijing, Beijing, China, 101200
      • Beijing Pinggu Hospital
    • Beijing, Beijing, China, 102500
      • Beijing Yanhua Hospital
  • Chongqing
    • Chongqing, Chongqing, China, 400016
      • The First Affiliated Hospital of Chongqing Medical University
    • Chongqing, Chongqing, China, 400010
      • Chongqing Medical University Second Afflicated Hospital
    • Chongqing, Chongqing, China, 400013
      • Chongqing Zhongshan Hospital
    • Chongqing, Chongqing, China, 400014
      • Chongqing Third People's Hospital
    • Chongqing, Chongqing, China, 400042
      • Da Ping Hospital
    • Chongqing, Chongqing, China, 402160
      • The Second People's Hospital of Chongqing
  • Fujian
    • Fuzhou, Fujian, China, 350001
      • Fujian Provincial Hospital
    • Fuzhou, Fujian, China, 350001
      • Union Hospital Affiliated to Fujian Medical University
    • Fuzhou, Fujian, China, 350004
      • The People's Hospital of Fujian Province
    • Xiamen, Fujian, China, 361004
      • Zhongshan Hospital Xiamen University
    • Xiamen, Fujian, China, 361003
      • The First Hospital of Xiamen
  • Guangdong
    • Guangzhou, Guangdong, China, 510080
      • The First Affiliated Hospital of Sun Yat-sen University
    • Guangzhou, Guangdong, China, 510120
      • Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    • Guangzhou, Guangdong, China, 510080
      • Guangdong General Hospital
    • Guangzhou, Guangdong, China, 510630
      • The First Affiliated Hospital of Jinan University
    • Guangzhou, Guangdong, China, 510150
      • The Third Affiliated Hospital of Guangzhou Medical College
    • Guangzhou, Guangdong, China, 510080
      • The First Affiliated Hospital of Guangdong Pharmaceutical University
    • Guangzhou, Guangdong, China, 510507
      • Wu Jing Zhong Dui Hospital of Guangdong Province
    • Shenzhen, Guangdong, China, 518036
      • Peking University Shenzhen Hospital
    • Zhongshan, Guangdong, China, 528403
      • Zhong Shan City People's Hospital
    • Zhuhai, Guangdong, China, 519000
      • The Fifth Affiliated Hospital of Sun Yat-sen University
  • Guangxi
    • Liuzhou, Guangxi, China, 545005
      • Liuzhou Worker's Hospital
    • Liuzhou, Guangxi, China, 545006
      • Liuzhou People's Hospital
    • Nanning, Guangxi, China, 530021
      • The First Affiliated Hospital of Guangxi Medical University
    • Nanning, Guangxi, China, 530001
      • Minzu Hospital of Guangxi Zhuang Autonomous Region
    • Nanning, Guangxi, China, 530021
      • 303 Hospital of People's Liberation Army
  • Guizhou
    • Guiyang, Guizhou, China, 550004
      • The affiliated Hospital of Guiyang Medical College
  • Hebei
    • Cangzhou, Hebei, China, 062650
      • Cangzhou Central Hospital
    • Shijiazhuang, Hebei, China, 050000
      • The Second Hospital of Hebei Medical University
    • Shijiazhuang, Hebei, China, 050031
      • The First Hospital Of Hebei Medical University
    • Shijiazhuang, Hebei, China, 050082
      • Bethune International Peace Hospital
    • Tangshan, Hebei, China, 063000
      • Tangshan Workers Hospital
    • Tangshan, Hebei, China, 063000
      • The Affiliated Hospital of North China Coal Medical University
    • Tangshan, Hebei, China, 064100
      • Yu Tian County Hospital
    • Zhangjiakou, Hebei, China, 075000
      • The Third Affiliated Hospital of Hebei North University
  • Heilongjiang
    • Da Qing, Heilongjiang, China, 163001
      • Da Qing Oilfield General Hospital
    • Harbin, Heilongjiang, China, 150001
      • The Fourth Affiliated Hospital of Harbin Medical University
  • Henan
    • Luoyang, Henan, China, 471003
      • The First Affiliated Hospital of Henan Science & Technology University
    • Luoyang, Henan, China, 471009
      • Luo Yang Central Hospital, Affiliated to Zhengzhou University
    • ZhengZhou, Henan, China, 450014
      • The Second Affiliated Hospital of Zhengzhou University
    • Zhengzhou, Henan, China, 450000
      • The First Affiliated Hospital of Henan College of TCM
    • Zhengzhou, Henan, China, 450003
      • The People's Hospital of Zhengzhou
  • Hubei
    • Wuhan, Hubei, China, 430071
      • Zhongnan Hospital of Wuhan University
    • Wuhan, Hubei, China, 430060
      • Renmin Hospital of Wuhan University
    • Wuhan, Hubei, China, 430022
      • Wuhan Asia Heart Hospital
    • Wuhan, Hubei, China, 430022
      • Union Hospital of Tongji Medical College of Huazhong
    • Wuhan, Hubei, China, 430030
      • Tongji Hospital of Tongji Medical College of Huazhong
    • Wuhan, Hubei, China, 430033
      • Pu'ai Hospital of Wuhan City
  • Hunan
    • Changsha, Hunan, China, 410008
      • Xiangya Hospital Central-South University
    • Changsha, Hunan, China, 410015
      • The Third Hospital of Changsha
    • Changsha, Hunan, China, 410005
      • Hunan Provincial People's Hospital
    • Changsha, Hunan, China, 410006
      • The Fourth Hospital of Changsha
  • Inner Mongolia
    • Baotou, Inner Mongolia, China, 014010
      • The first affiliated hospital of Baotou medical college
    • Baotou, Inner Mongolia, China, 014040
      • Baotou Central Hospital
    • Chifeng, Inner Mongolia, China, 024000
      • Chifeng Municipal Hospital
    • Hohhot, Inner Mongolia, China, 010017
      • Inner Mongolia Hospital
  • Jiangsu
    • NanJing, Jiangsu, China, 210002
      • 81st Hospital of Chinese PLA
    • NanJing, Jiangsu, China, 210024
      • Jiangsu Province Official Hospital
    • NanJing, Jiangsu, China, 210029
      • Jiangsu Provincial Hospital of TCM
    • Nanjing, Jiangsu, China, 210008
      • Nanjing Drum Tower Hospital
    • Nanjing, Jiangsu, China, 210029
      • Jiangsu Province Hospital
    • Nanjing, Jiangsu, China, 210006
      • Nanjing First Hospital
    • Nanjing, Jiangsu, China, 211100
      • Nanjing Jiangning Hospital
    • Nanjing, Jiangsu, China, 210009
      • Nanjing Zhongda Hospital
    • Nanjing, Jiangsu, China, 210017
      • BENQ Hospital
    • Suzhou, Jiangsu, China, 215000
      • Suzhou Municipal Hospital
    • Wuxi, Jiangsu, China, 214023
      • Wuxi People's Hospital
    • Wuxi, Jiangsu, China, 214002
      • Wuxi No.2 People's Hospital
    • Wuxi, Jiangsu, China, 214041
      • Wuxi No.3 People's Hospital
    • Xuzhou, Jiangsu, China, 221000
      • Hospital Affiliated Xuzhou Medical University
    • Xuzhou, Jiangsu, China, 221006
      • The Second Affiliated Hospital of Xuzhou Medical University
    • Zhenjiang, Jiangsu, China, 212002
      • Zhenjiang First People's Hospital
  • Jiangxi
    • Jiujiang, Jiangxi, China, 332000
      • Jiujiang University Hospital
    • Nanchang, Jiangxi, China, 330006
      • The Second Affiliated Hospital of Nanchang University
    • Nanchang, Jiangxi, China, 330006
      • Jiangxi Provincial People's Hospital
    • Nanchang, Jiangxi, China, 330008
      • The Third Affiliated Hospital of Nanchang University
  • Jilin
    • Changchun, Jilin, China, 130033
      • China-Japan Union Hospital of Jilin University
    • Changchun, Jilin, China, 130041
      • The Second Hospital of Jilin University
  • Liaoning
    • Anshan, Liaoning, China, 114001
      • The Central Hospital of Anshan
    • Dalian, Liaoning, China, 116011
      • The First Hospital of Dalian Medical University
    • Dalian, Liaoning, China, 116001
      • Affiliated Zhongshan hospital of Dalian university
    • Dalian, Liaoning, China, 116033
      • Dalian Central Hospital
    • Shengyang, Liaoning, China, 712000
      • Xianyang Central Hospital
    • Shenyang, Liaoning, China, 110016
      • The People's Hospital of Liaoning Province
    • Shenyang, Liaoning, China, 110004
      • Shengjing Hospital of China Medical University
    • Shenyang, Liaoning, China, 110021
      • Shengjing Hospital of China Medical University
    • Shenyang, Liaoning, China, 110032
      • The Fourth Hospital of China Medical University
  • Ningxia
    • Yinchuan, Ningxia, China, 750004
      • Affiliated Hospital of Ningxia Medical University
    • Yinchuan, Ningxia, China, 750001
      • The First Hospital of Yinchuan
    • Yinchuan, Ningxia, China, 750021
      • The People's Hospital of Ningxia Hui Autonomous Region
  • Shaanxi
    • Xi'an, Shaanxi, China, 710061
      • The First Affiliated Hospital of Xi'an Jiaotong University
    • Xi'an, Shaanxi, China, 710003
      • Xi'an Central Hospital
    • Xi'an, Shaanxi, China, 710077
      • Affiliated Hospital of Xi'an Medical college
    • Yan'an, Shaanxi, China, 716000
      • Affiliated Hospital of Yan'an University
    • Yanan, Shaanxi, China, 716000
      • Yan'an People's Hospital
    • Yulin, Shaanxi, China, 719000
      • The First Hospital of Yulin
  • Shandong
    • Jinan, Shandong, China, 250013
      • The Central Hospital of Jinan
    • Jinan, Shandong, China, 250013
      • The First People's Hospital of Jinan
    • Jinan, Shandong, China, 250031
      • The General Hospital of Jinan Military Region
    • Linyi, Shandong, China, 276003
      • Linyi People's Hospital
    • Qingdao, Shandong, China, 266003
      • Hospital Affiliated of Medical School, Qingdao University
    • Qingdao, Shandong, China, 266011
      • The Qingdao Municiple Hospital
    • Shibei, Shandong, China, 266034
      • Qingdao Fuwai Hospital
    • Taian, Shandong, China, 271000
      • Taian City Central Hospital
  • Shanghai
    • Shanghai, Shanghai, China, 200433
      • Changhai Hospital
    • Shanghai, Shanghai, China, 200120
      • Shanghai East hospital
    • Shanghai, Shanghai, China, 200011
      • Shanghai Ninth People's Hospital
    • Shanghai, Shanghai, China, 200092
      • Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
    • Shanghai, Shanghai, China, 200072
      • Shanghai Tenth People's Hospital
    • Shanghai, Shanghai, China, 200032
      • Shanghai Zhongshan Hospital
    • Shanghai, Shanghai, China, 200065
      • Tongji Hospital of Tongji University
    • Shanghai, Shanghai, China, 200135
      • Shanghai Pudong New Area Gongli Hospital
    • Shanghai, Shanghai, China, 200025
      • Ruijin Hospital Affiliated to the Shanghai Jiaotong University Medical School
    • Shanghai, Shanghai, China, 200031
      • Shanghai Central Hospital of Xuhui District
    • Shanghai, Shanghai, China, 200040
      • Shanghai Huadong Hospital
    • Shanghai, Shanghai, China, 200060
      • Shanghai Putuo District People's Hospital
    • Shanghai, Shanghai, China, 200062
      • Putuo District Center Hospital
    • Shanghai, Shanghai, China, 200081
      • Number 411 Hospital of PLA
    • Shanghai, Shanghai, China, 200090
      • Shanghai Central Hospital of Yangpu District
    • Shanghai, Shanghai, China, 200127
      • Renji Hospital Affilicated to Jiaotong University School of Medicine
    • Shanghai, Shanghai, China, 200435
      • Shanghai Zhabei District Shibei Hospital
    • Shanghai, Shanghai, China, 200540
      • Shanghai Jinshan Hospital
    • Shanghai, Shanghai, China, 201200
      • Shanghai Pudong New District People's Hospital
  • Shanxi
    • Taiyuan, Shanxi, China, 030024
      • Shanxi Cardiovascular Hospital
    • Taiyuan, Shanxi, China, 030003
      • General Hospital of TISCO
    • Taiyuan, Shanxi, China, 030006
      • The Third Engineering Bureau Hospital of Ministry of Railway
    • Taiyuan, Shanxi, China, 030009
      • Taiyuan City Central Hospital
    • Xi'an, Shanxi, China, 710054
      • PLA No.323 Hospital
  • Sichuan
    • Chengdu, Sichuan, China, 610017
      • ChengDu Second People's Hospital
    • Chengdu, Sichuan, China, 610016
      • Chengdu First People's Hospital
    • Chengdu, Sichuan, China, 610041
      • Sichuan Provincial People's Hospital
    • Chengdu, Sichuan, China, 610041
      • The West China Hospital
    • Sichuan, Sichuan, China, 621000
      • Sichuan Mianyang 404 Hospital
  • Tianjin
    • Tianjin, Tianjin, China, 300051
      • Tianjin Chest Hospital
    • Tianjin, Tianjin, China, 300170
      • Tianjin Third Central Hospital
    • Tianjin, Tianjin, China, 300211
      • The Second Hospital of Tianjin Medical University
    • Tianjin, Tianjin, China, 300192
      • Tianjin First Center Hospital
    • Tianjin, Tianjin, China, 300050
      • Tianjin Union Hospital
    • Tianjin, Tianjin, China, 300121
      • Tianjin Union Medicine Centre
    • Tianjin, Tianjin, China, 300162
      • Army Police's Medical College Affiliated Hospital
    • Tianjin, Tianjin, China, 300280
      • Dagang Oil-Field General Hospital
    • Tianjin, Tianjin, China, 300450
      • The Fifth Central Hospital of Tianjin
  • Xinjiang
    • Shihezi, Xinjiang, China, 832008
      • First Affiliated Hospital of the Medical College
    • Urumqi, Xinjiang, China, 830054
      • The First Teaching Hospital of Xinjiang Medical University
    • Urumqi, Xinjiang, China, 830000
      • Xin Jiang Traditional Chinese Medicine Hospital
    • Urumqi, Xinjiang, China, 830002
      • General Hospital of Xinjiang Production and Construction Corps
    • Urumqi, Xinjiang, China, 830013
      • The 474th Hospital of PLA
  • Yunnan
    • Kunming, Yunnan, China, 650032
      • The First Affiliated Hospital of Kunming Medical College
    • Kunming, Yunnan, China, 650032
      • The First People's Hospital of Yunnan Province
    • Kunming, Yunnan, China, 650101
      • The Second Affiliated Hospital of Kunming Medical College
    • Yuxi, Yunnan, China, 653100
      • People's Hospital of Yuxi City
  • Zhejiang
    • Hangzhou, Zhejiang, China, 310013
      • Zhe Jiang Hospital
    • Hangzhou, Zhejiang, China, 310016
      • Sir Run Run Shaw Hospital Affiliated With School of Medicine, Zhe Jiang University
• Hong Kong
  • Hong Kong, Hong Kong
    • Prince of Wales Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 50 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Male or female, aged 50 years or more.

• Definite CHD, defined as a, b or c below:

  1. Previous myocardial infarction (MI) or Acute Coronary Syndrome (ACS), but not within the last 3 months, with any two of the following:

     • Typical clinical presentation
     • Confirmatory ECG changes
     • Appropriate elevation of cardiac enzymes/biomarkers

  2. Previous unstable angina (UA) or Acute Coronary Syndrome (ACS), but not within the last 3 months, with any two of the following:

     • Typical clinical presentation
     • Confirmatory ECG changes
     • Either elevation of a cardiac biomarker or a >50% stenosis in ≥1 major epicardial coronary artery shown on coronary angiography or CT angiography. Where stenosis is reported in a qualitative manner, the categories "moderate" and "severe" will be taken as equating to >50% stenosis.

  3. Current stable angina defined as:

     • Typical clinical history with symptoms occurring within the last month, and
     • A >50% stenosis in ≥1 major epicardial coronary artery shown on coronary angiography or CT angiography. Where stenosis is reported in a qualitative manner, the categories "moderate" and "severe" will be taken as equating to >50% stenosis.
• Impaired glucose tolerance diagnosed on a single standard oral glucose tolerance test (OGTT) , defined as a 2-hour plasma glucose (2HPG) value ≥7.8 but <11.1 mmol/l and a fasting plasma glucose (FPG) <7.0 mmol/l within six months prior to enrollment.
• Optimised cardiovascular drug therapy.
• At least 80% adherent to single blind placebo Study Medication during the run-in period.
• Provision of written informed consent.

Exclusion Criteria:

• Previous history of diabetes, other than gestational diabetes.
• MI, unstable angina, stroke or a transient ischaemic attack (TIA) within the previous three months.
• Planned or anticipated coronary, cerebrovascular or peripheral arterial revascularisation or other major surgical intervention, at the time of randomisation
• New York Heart Association (NYHA) class III or IV heart failure.
• Evidence of severe hepatic disease.
• Evidence of severe renal impairment or an eGFR <30 ml/min/1.73m2 (derived using the Modification of Diet in Renal Disease, MDRD, Chinese equation)
• Any other condition likely to reduce adherence to the protocol e.g. alcoholism, major active psychiatric disorder, cognitive impairment or a condition likely to markedly limit life expectancy e.g. malignancy.
• Pregnancy (or planned pregnancy within the next five years).
• Concurrent participation in any other clinical interventional trial. Note: Patients who were treated previously with an alphaglucosidase inhibitor must have at least a three-month washout period before being randomised into the ACE trial.
• Known intolerance to alpha glucosidase inhibitors or gastrointestinal problems.
• Thought by the investigator for any reason to be unsuitable for participation in this clinical study.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Quadruple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Acarbose; The participants were given one tablet (50mg) of acarbose per day, taken with a meal during their first week (7 days). During the second week, the dose was increased to two tablets/day (50mg twice a day i.e. 100mg/day) and then three tablets/day (50mg three times a day i.e. 150mg/day) thereafter. The maximum tolerated dose is being taken for the duration of the trial (maximum dose is 150mg/day).	Drug: Acarbose; The participants were given one tablet (50mg) of acarbose per day, taken with a meal during their first week (7 days). During the second week, the dose was increased to two tablets/day (50mg twice a day i.e. 100mg/day) and then three tablets/day (50mg three times a day i.e. 150mg/day) thereafter. The maximum tolerated dose is being taken for the duration of the trial (maximum dose is 150mg/day).; Other Names: Glucobay
Placebo Comparator: Matching Placebo; The participants were given one tablet of matching placebo per day, taken with a meal during their first week (7 days). During the second week, the dose was increased to two tablets/day and then three tablets/day thereafter. The maximum tolerated dose is being taken for the duration of the trial (maximum dose is 3 tablets/day).	Drug: Matching Placebo; The participants were given one tablet of matching placebo per day, taken with a meal during their first week (7 days). During the second week, the dose was increased to two tablets/day and then three tablets/day thereafter. The maximum tolerated dose is being taken for the duration of the trial (maximum dose is 3 tablets/day).

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
A composite cardiovascular outcome defined as the time after randomisation to the first occurrence of any one of the following: -Cardiovascular death -Non-fatal MI -Non-fatal stroke -Hospitalisation for Unstable Angina -Hospitalisation for Heart Failure	Follow-up until 728 adjudicated Primary Outcome Measures have been recorded

Secondary Outcome Measures

Outcome Measure
All cause mortality
Transition to type 2 diabetes confirmed by two successive diagnostic plasma glucose values (FPG >7.0 mmol/l and/or 2HPG > 11.1 mmol/l), with no intervening non-diagnostic values.
Each of the components of the primary composite cardiovascular outcome will also be analysed individually, both as first and as total events.
Major Cardiovascular Event (MACE) composite cardiovascular outcome, defined as the time after randomisation to the first occurrence of any one of the following: - Cardiovascular death - Non-fatal MI - Non-fatal stroke
Impaired renal function as evidenced by: A reduced estimate of glomerular filtration rate( eGFR <30 ml/minute/ 1.73 m2) estimated using the Chinese MDRD formula, a doubling of the baseline plasma creatinine level, a halving of the baseline eGFR
Resource use, costs and cost effectiveness

Collaborators and Investigators

• Sponsor: University of Oxford
• Collaborators: Bayer
• Investigators: Principal Investigator: Professor Rury R Holman, FRCP FMedSci, Diabetes Trials Unit, University of Oxford

Publications and helpful links

General Publications

• Wamil M, McMurray JJV, Scott CAB, Coleman RL, Sun Y, Standl E, Ryden L, Holman RR. Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trial. Diabetes Res Clin Pract. 2020 Dec;170:108488. doi: 10.1016/j.diabres.2020.108488. Epub 2020 Oct 6.
• Gerstein HC, Coleman RL, Scott CAB, Xu S, Tuomilehto J, Ryden L, Holman RR; ACE Study Group. Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial. Diabetes Care. 2020 Sep;43(9):2242-2247. doi: 10.2337/dc19-2046. Epub 2020 Jul 8.
• Holman RR, Coleman RL, Chan JCN, Chiasson JL, Feng H, Ge J, Gerstein HC, Gray R, Huo Y, Lang Z, McMurray JJ, Ryden L, Schroder S, Sun Y, Theodorakis MJ, Tendera M, Tucker L, Tuomilehto J, Wei Y, Yang W, Wang D, Hu D, Pan C; ACE Study Group. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017 Nov;5(11):877-886. doi: 10.1016/S2213-8587(17)30309-1. Epub 2017 Sep 13. Erratum In: Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7. Lancet Diabetes Endocrinol. 2019 May;7(5):e5.

Helpful Links

• Diabetes Trials Unit, International Co-ordinating Centre for the ACE Trial

Study record dates

Study Major Dates

• Study Start (Actual): February 17, 2009
• Primary Completion (Actual): April 11, 2017
• Study Completion (Actual): April 18, 2017

Study Registration Dates

• First Submitted: January 26, 2009
• First Submitted That Met QC Criteria: January 26, 2009
• First Posted (Estimate): January 27, 2009

Study Record Updates

• Last Update Posted (Actual): July 25, 2017
• Last Update Submitted That Met QC Criteria: July 21, 2017
• Last Verified: July 1, 2017

More Information

Terms related to this study

• Keywords: Acarbose
• Additional Relevant MeSH Terms: Pathologic Processes; Cardiovascular Diseases; Vascular Diseases; Glucose Metabolism Disorders; Metabolic Diseases; Arteriosclerosis; Arterial Occlusive Diseases; Endocrine System Diseases; Disease; Diabetes Mellitus; Hyperglycemia; Heart Diseases; Coronary Artery Disease; Myocardial Ischemia; Coronary Disease; Diabetes Mellitus, Type 2; Syndrome; Glucose Intolerance; Acute Coronary Syndrome; Hypoglycemic Agents; Physiological Effects of Drugs; Molecular Mechanisms of Pharmacological Action; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Acarbose
• Other Study ID Numbers: 11232; ISRCTN91899513

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED